SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024724
Filing Date
2022-11-14
Accepted
2022-11-14 08:18:12
Documents
51
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q life-20220930.htm   iXBRL 10-Q 2849267
2 EX-3.1 life-ex3_1.htm EX-3.1 335942
3 EX-3.6 life-ex3_6.htm EX-3.6 198639
4 EX-31.1 life-ex31_1.htm EX-31.1 14517
5 EX-31.2 life-ex31_2.htm EX-31.2 14620
6 EX-32.1 life-ex32_1.htm EX-32.1 10468
7 EX-32.2 life-ex32_2.htm EX-32.2 9772
  Complete submission text file 0000950170-22-024724.txt   8979278

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT life-20220930_lab.xml EX-101.LAB 375018
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT life-20220930.xsd EX-101.SCH 40816
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT life-20220930_cal.xml EX-101.CAL 49955
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT life-20220930_def.xml EX-101.DEF 149924
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT life-20220930_pre.xml EX-101.PRE 261786
45 EXTRACTED XBRL INSTANCE DOCUMENT life-20220930_htm.xml XML 1526696
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 221380538
SIC: 2836 Biological Products, (No Diagnostic Substances)